Skip to main content
letter
. 2022 Aug 17;85(5):e140–e144. doi: 10.1016/j.jinf.2022.08.008

Table 1.

Baseline characteristics of cases and controls. ICU: intensive care unit. All parameters are expressed in either number (percentage) or mean (SD).

Baseline characteristics Infection
Hospitalisation
ICU admission or ventilatory support
CVD
All-cause mortality
Cases Controls Cases Controls Cases Controls Cases Controls Cases Controls
Number of individuals 82,587 329,560 10,241 100,320 539 5252 135 1335 2898 28,056
Age, years 67.82 (12.51) 67.84 (12.41) 77.69 (12.13) 77.69 (11.79) 76.13 (12.26) 76.30 (11.75) 76.67 (11.74) 76.34 (11.75) 82.86 (9.88) 82.70 (9.55)
Sex, male 44,435 (53.8) 177,349 (53.8) 5679 (55.5) 55,850 (55.7) 314 (58.3) 3052 (58.1) 68 (50.4) 672 (50.3) 1725 (59.5) 16,828 (60.0)
HbA1c,% (mmol/mol) 6.96 (53) (1.19) 6.91 (52) (1.07) 6.94 (52) (1.38) 6.91 (52) (1.12) 7.04 (53) (1.54) 6.92 (52) (1.14) 7.13 (54) (1.25) 6.90 (52) (1.00) 6.92 (52) (1.46) 6.92 (52) (1.17)
Charlson Comorbidity Index 3.61 (1.89) 3.56 (1.81) 5.32 (2.14) 5.10 (2.02) 5.22 (2.16) 5.04 (2.10) 4.30 (1.67) 4.16 (1.48) 6.30 (2.13) 5.98 (1.99)
Pre-existing comorbidities
Hypertension 55,905 (67.7) 228,158 (69.2) 7359 (71.9) 78,251 (78.0) 384 (71.2) 4021 (76.6) 79 (58.5) 961 (72.0) 2143 (73.9) 23,086 (82.3)
Cancer 3680 (4.5) 12,546 (3.8) 947 (9.2) 9161 (9.1) 39 (7.2) 491 (9.3) 5 (3.7) 50 (3.7) 297 (10.2) 3245 (11.6)
Chronic Kidney Disease 4497 (5.4) 19,617 (6.0) 1729 (16.9) 16,151 (16.1) 114 (21.2) 885 (16.9) 12 (8.9) 78 (5.8) 666 (23.0) 6614 (23.6)
Respiratory disease 3006 (3.6) 9698 (2.9) 826 (8.1) 5736 (5.7) 41 (7.6) 294 (5.6) 2 (1.5) 35 (2.6) 282 (9.7) 2351 (8.4)
Coronary Heart Disease 8235 (10.0) 29,217 (8.9) 1791 (17.5) 12,930 (12.9) 103 (19.1) 722 (13.7) 0 (0.0) 0 (0.0) 721 (24.9) 4530 (16.1)
Stroke 7873 (9.5) 27,910 (8.5) 2203 (21.5) 16,319 (16.3) 111 (20.6) 818 (15.6) 0 (0.0) 0 (0.0) 877 (30.3) 5986 (21.3)
Heart Failure 3373 (4.1) 9111 (2.8) 1349 (13.2) 7153 (7.1) 73 (13.5) 413 (7.9) 0 (0.0) 0 (0.0) 560 (19.3) 3240 (11.5)
Dementia 917 (1.1) 1756 (0.5) 501 (4.9) 1771 (1.8) 27 (5.0) 93 (1.8) 5 (3.7) 5 (0.4) 234 (8.1) 857 (3.1)
Medication use
Oral anti-diabetic drugs 62,696 (75.9) 254,833 (77.3) 7333 (71.6) 73,019 (72.8) 384 (71.2) 3831 (72.9) 109 (80.7) 996 (74.6) 1921 (66.3) 19,380 (69.1)
Insulin 10,795 (13.1) 31,178 (9.5) 2662 (26.0) 11,649 (11.6) 154 (28.6) 688 (13.1) 25 (18.5) 120 (9.0) 1606 (55.4) 3643 (13.0)
Renin-angiotensin-system agents 44,554 (53.9) 180,751 (54.8) 5630 (55.0) 58,366 (58.2) 306 (56.8) 3032 (57.7) 82 (60.7) 744 (55.7) 1468 (50.7) 16,290 (58.1)
Beta-blockers 23,306 (28.2) 91,318 (27.7) 3788 (37.0) 31,887 (31.8) 218 (40.4) 1744 (33.2) 48 (35.6) 387 (29.0) 1151 (39.7) 9155 (32.6)
Calcium channel blockers 47,403 (57.4) 193,345 (58.7) 6232 (60.9) 65,400 (65.2) 327 (60.7) 3399 (64.7) 77 (57.0) 882 (66.1) 1745 (60.2) 18,574 (66.2)
Diuretics 9895 (12.0) 29,073 (8.8) 2902 (28.3) 14,343 (14.3) 168 (31.2) 814 (15.5) 19 (14.1) 135 (10.1) 1211 (41.8) 5023 (17.9)
Nitrates 6064 (7.3) 16,781 (5.1) 1533 (15.0) 8436 (8.4) 87 (16.1) 426 (8.1) 13 (9.6) 46 (3.4) 544 (18.8) 2928 (10.4)
Lipid-lowering agents 59,383 (71.9) 246,231 (74.7) 7134 (69.7) 75,808 (75.6) 364 (67.5) 3909 (74.4) 89 (65.9) 969 (72.6) 1854 (64.0) 20,822 (74.2)
Oral anticoagulants 2907 (3.5) 8238 (2.5) 887 (8.7) 5166 (5.1) 48 (8.9) 259 (4.9) 7 (5.2) 40 (3.0) 299 (10.3) 1993 (7.1)
Antiplatelets 19,532 (23.7) 70,071 (21.3) 4321 (42.2) 31,051 (31.0) 236 (43.8) 1639 (31.2) 35 (25.9) 211 (15.8) 1511 (52.1) 10,058 (35.8)
Immunosuppressants 646 (0.8) 1811 (0.5) 210 (2.1) 561 (0.6) 13 (2.4) 38 (0.7) 2 (1.5) 4 (0.3) 197 (6.8) 143 (0.5)